Product Information
CHLORDIAZEPOX-AMITRIPTYL 10-25 is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.5774 per EA under NDC 00378027701. Its NADAC has been published 416 times since Nov 28, 2013.
FDA first approved this application on Dec 10, 1986.
Strength
27.98; 10 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378027701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071297FDA Approved
12/10/1986
On Market Since
12/10/1986
Pharmacological Classes
Price Statistics
The NADAC for CHLORDIAZEPOX-AMITRIPTYL 10-25 has been published 416 times since Nov 28, 2013, and over the history we have for it it has risen 24.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5774 per EA |
|---|---|
| All-time high | $1.7522 (Sep 10, 2014) |
| All-time low | $1.2629 (Nov 28, 2013) |
| 52-week high | $1.5774 |
| 52-week low | $1.5774 |
| Median price | $1.6331 |
| Average price | $1.6126 |
| Largest weekly change | +13.8% (Jul 23, 2014) |
| Weeks tracked | 416 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
-5.1%
5Y
-5.1%
All
+24.9%
Last surveyed Jun 10, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHLORDIAZEPOX-AMITRIPTYL 10-25?
The current National Average Drug Acquisition Cost (NADAC) for CHLORDIAZEPOX-AMITRIPTYL 10-25, manufactured by Mylan Pharmaceuticals Inc., is $1.5774 per EA (NDC 00378027701), effective Jun 10, 2026.
How has the price of CHLORDIAZEPOX-AMITRIPTYL 10-25 changed over time?
Over the history we have for it, the NADAC for CHLORDIAZEPOX-AMITRIPTYL 10-25 has risen 24.9%. It has been tracked across 416 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CHLORDIAZEPOX-AMITRIPTYL 10-25?
Since Nov 28, 2013, the NADAC for CHLORDIAZEPOX-AMITRIPTYL 10-25 has ranged from a low of $1.2629 (Nov 28, 2013) to a high of $1.7522 (Sep 10, 2014), with a median of $1.6331 per EA.
Are there cheaper alternatives to CHLORDIAZEPOX-AMITRIPTYL 10-25?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CHLORDIAZEPOX-AMITRIPTYL 10-25 in a comparable dosage form, but none are currently priced below it.
Who manufactures CHLORDIAZEPOX-AMITRIPTYL 10-25?
CHLORDIAZEPOX-AMITRIPTYL 10-25 (NDC 00378027701) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.